SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-001238
Filing Date
2017-05-15
Accepted
2017-05-15 13:34:47
Documents
40
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT proteo_10q-033117.htm 10-Q 162305
2 LETTER AGREEMENT DATED APRIL 10, 2017, BETWEEN REGISTRANT AND DR. OLIVER WIEDOW proteo_10q-ex1025.htm EX-10.25 8507
3 CERTIFICATION proteo_10q-ex3101.htm EX-31.1 8010
4 CERTIFICATION proteo_10q-ex3102.htm EX-31.2 8270
5 CERTIFICATION proteo_10q-ex32.htm EX-32 5552
  Complete submission text file 0001683168-17-001238.txt   963879

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pteo-20170331.xml EX-101.INS 88552
7 XBRL SCHEMA FILE pteo-20170331.xsd EX-101.SCH 13595
8 XBRL CALCULATION FILE pteo-20170331_cal.xml EX-101.CAL 28677
9 XBRL DEFINITION FILE pteo-20170331_def.xml EX-101.DEF 21642
10 XBRL LABEL FILE pteo-20170331_lab.xml EX-101.LAB 90021
11 XBRL PRESENTATION FILE pteo-20170331_pre.xml EX-101.PRE 73575
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 17842987
SIC: 2834 Pharmaceutical Preparations